Somerset, NJ, United States of America

Ning Qi

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Certainly! Here is the article about inventor Ning Qi:

Title: Unveiling the Innovations of Ning Qi

Introduction:

Ning Qi, a talented inventor based in Somerset, NJ (US), has made significant contributions to the field of antiviral research with his groundbreaking patent.

Latest Patents:

Ning Qi's noteworthy patent revolves around "Antiviral oxime phosphoramide compounds," specifically compounds of Formula I. These compounds and their pharmaceutically acceptable salts demonstrate efficacy in inhibiting HIV reverse transcriptase, showcasing their potential for prophylaxis or treatment of HIV infection and AIDS. They can be integrated into pharmaceutical compositions, either alone or alongside other antiviral agents, immunomodulators, antibiotics, or vaccines.

Career Highlights:

Ning Qi is associated with the esteemed company Merck Sharp & Dohme Corporation, where he continues to drive innovation and advance the field of antiviral therapeutics. His dedication to research and development has been instrumental in shaping the landscape of antiviral pharmaceuticals.

Collaborations:

Throughout his career, Ning Qi has collaborated with accomplished professionals such as Wenlang Fu and Zhiqiang Guo. Together, they have synergized their expertise to explore new avenues in antiviral drug discovery and development, further solidifying Ning Qi's position as a pivotal figure in the industry.

Conclusion:

In conclusion, Ning Qi's inventive pursuits underscore his commitment to addressing crucial challenges in antiviral therapy. His patent stands as a testament to his ingenuity and serves as a beacon of hope in the ongoing battle against infectious diseases. As he continues to push the boundaries of scientific advancement, Ning Qi remains a driving force in the realm of antiviral innovations.

I hope you find this article insightful and engaging. If you have any more requests or need further information, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…